Literature DB >> 17260051

Refractory epilepsy: one size does not fit all.

Jacqueline A French1.   

Abstract

A unifying definition of refractory epilepsy has been hotly debated but, to date, has not been agreed upon. Evidence from clinical trials indicates that some patients actually are not refractory, as many will partially respond to add-on treatment or will worsen when antiepileptic drugs (AEDs) are removed. There are several important issues relating to the assessment of AED response that routinely have not been addressed in the determination of treatment responsiveness, such as incorporating baseline seizure severity, including partial response rather than solely an all-or-none response, and the consideration of variability in response over time.

Entities:  

Year:  2006        PMID: 17260051      PMCID: PMC1783491          DOI: 10.1111/j.1535-7511.2006.00137.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.500


  24 in total

Review 1.  Historical control withdrawal to monotherapy.

Authors:  Jacqueline French
Journal:  Epilepsy Res       Date:  2006-01       Impact factor: 3.045

Review 2.  Historical data in the design and interpretation of trials with newly diagnosed patients.

Authors:  Michel Baulac
Journal:  Epilepsy Res       Date:  2006-01       Impact factor: 3.045

3.  Defining intractability: comparisons among published definitions.

Authors:  Anne T Berg; Molly M Kelly
Journal:  Epilepsia       Date:  2006-02       Impact factor: 5.864

4.  Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1.

Authors:  Asra Siddiqui; Reinhold Kerb; Michael E Weale; Ulrich Brinkmann; Alice Smith; David B Goldstein; Nicholas W Wood; Sanjay M Sisodiya
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

Review 5.  Defining success in clinical trials--profiling pregabalin, the newest AED.

Authors:  P Ryvlin
Journal:  Eur J Neurol       Date:  2005-11       Impact factor: 6.089

6.  Antiepileptic drug withdrawal after successful surgery for intractable temporal lobe epilepsy.

Authors:  Young Dae Kim; Kyoung Heo; Soo Chul Park; Kyoon Huh; Jin Woo Chang; Joong Uhn Choi; Sang Sup Chung; Byung In Lee
Journal:  Epilepsia       Date:  2005-02       Impact factor: 5.864

7.  Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study.

Authors:  Matti Sillanpää; Dieter Schmidt
Journal:  Brain       Date:  2006-01-09       Impact factor: 13.501

8.  Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs.

Authors:  Yun-Sil Lee; Hyungsuk Kim; Tian-Xia Wu; Xiao-Min Wang; Raymond A Dionne
Journal:  Clin Pharmacol Ther       Date:  2006-05       Impact factor: 6.875

9.  Diagnosing refractory epilepsy: response to sequential treatment schedules.

Authors:  R Mohanraj; M J Brodie
Journal:  Eur J Neurol       Date:  2006-03       Impact factor: 6.089

10.  Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood.

Authors:  Willem F M Arts; Oebele F Brouwer; A C Boudewijn Peters; Hans Stroink; Els A J Peeters; Paul I M Schmitz; Cees A van Donselaar; Ada T Geerts
Journal:  Brain       Date:  2004-06-16       Impact factor: 13.501

View more
  18 in total

Review 1.  Felbamate as an add-on therapy for refractory partial epilepsy.

Authors:  Li Li Shi; JianCheng Dong; HengJian Ni; JinSong Geng; Taixiang Wu
Journal:  Cochrane Database Syst Rev       Date:  2017-07-18

2.  Intrinsic severity as a determinant of antiepileptic drug refractoriness.

Authors:  Michael A Rogawski; Michael R Johnson
Journal:  Epilepsy Curr       Date:  2008 Sep-Oct       Impact factor: 7.500

Review 3.  Optogenetics: the new molecular approach to control functions of neural cells in epilepsy, depression and tumors of the central nervous system.

Authors:  Bruno Camporeze; Bruno Alcântara Manica; Gabriel Alves Bonafé; Jivago Jordão Camargos Ferreira; Aurélio Lourenço Diniz; Carlos Tadeu Parisi de Oliveira; Luis Roberto Mathias Junior; Paulo Henrique Pires de Aguiar; Manoela Marques Ortega
Journal:  Am J Cancer Res       Date:  2018-10-01       Impact factor: 6.166

Review 4.  Clobazam add-on therapy for drug-resistant epilepsy.

Authors:  Rebecca Bresnahan; Kirsty J Martin-McGill; John Williamson; Benedict D Michael; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-10-22

Review 5.  Felbamate add-on therapy for drug-resistant focal epilepsy.

Authors:  Li Li Shi; Rebecca Bresnahan; Kirsty J Martin-McGill; JianCheng Dong; HengJian Ni; JinSong Geng
Journal:  Cochrane Database Syst Rev       Date:  2022-08-01

Review 6.  Stiripentol add-on therapy for drug-resistant focal epilepsy.

Authors:  Francesco Brigo; Stanley C Igwe; Nicola Luigi Bragazzi
Journal:  Cochrane Database Syst Rev       Date:  2022-09-06

7.  Remission of epilepsy after two drug failures in children: a prospective study.

Authors:  Anne T Berg; Susan R Levy; Francine M Testa; Ramona D'Souza
Journal:  Ann Neurol       Date:  2009-05       Impact factor: 10.422

Review 8.  Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.

Authors:  Gashirai K Mbizvo; Pete Dixon; Jane L Hutton; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

9.  Felbamate add-on therapy for drug-resistant focal epilepsy.

Authors:  Li Li Shi; Rebecca Bresnahan; Kirsty J Martin-McGill; JianCheng Dong; HengJian Ni; JinSong Geng
Journal:  Cochrane Database Syst Rev       Date:  2019-08-01

10.  Subpial transection surgery for epilepsy.

Authors:  Balaji Krishnaiah; Sridharan Ramaratnam; Lakshmi Narasimhan Ranganathan
Journal:  Cochrane Database Syst Rev       Date:  2018-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.